- Home
- LGND vs ACHC Comparison
LGND vs ACHC Comparison
Compare LGND & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- ACHC
- Stock Information
- Founded
- LGND 1987
- ACHC 2005
- Country
- LGND United States
- ACHC United States
- Employees
- LGND N/A
- ACHC N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- ACHC Medical Specialities
- Sector
- LGND Health Care
- ACHC Health Care
- Exchange
- LGND Nasdaq
- ACHC Nasdaq
- Market Cap
- LGND 2.0B
- ACHC 2.1B
- IPO Year
- LGND 1992
- ACHC N/A
- Fundamental
- Price
- LGND $102.19
- ACHC $22.64
- Analyst Decision
- LGND Strong Buy
- ACHC Buy
- Analyst Count
- LGND 8
- ACHC 9
- Target Price
- LGND $144.71
- ACHC $47.94
- AVG Volume (30 Days)
- LGND 118.3K
- ACHC 2.4M
- Earning Date
- LGND 05-08-2025
- ACHC 05-12-2025
- Dividend Yield
- LGND N/A
- ACHC N/A
- EPS Growth
- LGND N/A
- ACHC N/A
- EPS
- LGND N/A
- ACHC 2.04
- Revenue
- LGND $181,488,000.00
- ACHC $3,156,417,000.00
- Revenue This Year
- LGND $17.68
- ACHC $7.86
- Revenue Next Year
- LGND $18.69
- ACHC $8.55
- P/E Ratio
- LGND N/A
- ACHC $11.10
- Revenue Growth
- LGND 53.40
- ACHC 5.48
- 52 Week Low
- LGND $77.43
- ACHC $20.36
- 52 Week High
- LGND $129.90
- ACHC $82.41
- Technical
- Relative Strength Index (RSI)
- LGND 44.63
- ACHC 40.69
- Support Level
- LGND $98.90
- ACHC $22.30
- Resistance Level
- LGND $103.17
- ACHC $23.58
- Average True Range (ATR)
- LGND 3.05
- ACHC 1.21
- MACD
- LGND -0.27
- ACHC -0.11
- Stochastic Oscillator
- LGND 31.94
- ACHC 7.59
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.